These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 24864512)
41. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. Bateman ED; Jacques L; Goldfrad C; Atienza T; Mihaescu T; Duggan M J Allergy Clin Immunol; 2006 Mar; 117(3):563-70. PubMed ID: 16522454 [TBL] [Abstract][Full Text] [Related]
42. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate. Zimmerman B; Gold M; Wherrett D; Hanna AK J Allergy Clin Immunol; 1998 Mar; 101(3):425-6. PubMed ID: 9525464 [No Abstract] [Full Text] [Related]
43. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD). Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579 [No Abstract] [Full Text] [Related]
44. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018 [TBL] [Abstract][Full Text] [Related]
45. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371 [TBL] [Abstract][Full Text] [Related]
46. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients. Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204 [TBL] [Abstract][Full Text] [Related]
47. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023). Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M; Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834 [TBL] [Abstract][Full Text] [Related]
48. Adrenal insufficiency after treatment with fluticasone. Dose-response curve should have been highlighted. Mohamed ASh BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378732 [No Abstract] [Full Text] [Related]
49. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma. Hoshino M; Handa H; Miyazawa T Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840 [TBL] [Abstract][Full Text] [Related]
50. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation]. Wettengel R; Steinkamp G Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652 [No Abstract] [Full Text] [Related]
51. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult. Hindmarsh P BMJ; 2002 May; 324(7345):1083. PubMed ID: 11993494 [No Abstract] [Full Text] [Related]
52. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819 [TBL] [Abstract][Full Text] [Related]
53. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs. O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769 [TBL] [Abstract][Full Text] [Related]